These findings not only illustrate the invasive and metastatic mechanism of ARHGEF37 in pulmonary metastasis, but also provide new therapeutic targets for the prevention and treatment of HCC pulmonary metastasis. This evidence concerns the gene ARHGEF37 and hepatocellular carcinoma.